A61K2236/17

Root extracts from plants of the <i>Morus </i>genus and uses of same

Disclosed is a root extract from plants of the Morus genus (in particular Morus albaet, Morus nigra) that is rich in prenylated polyphenols chosen from: moracenin A, moracenin B, kuwanon C, wittiorumin F and mulberrofuran T, a method for preparing such an extract and a cosmetic composition and a pharmaceutical or nutraceutical composition, the compositions including, as the active ingredient, at least one root extract from plants of the Morus genus according to the invention.

Cannabinoid formulation containing active ingredients and carrier for transdermal absorption to treat neuropathy
11717496 · 2023-08-08 ·

The invention relates to a topical formulation in order to deliver an effective amount of broad-spectrum cannabidiol ointment, in conjunction with active ingredients, menthol and camphor. This invention is for the treatment of symptoms and improvement of sensation associated with peripheral neuropathy, particularly of the feet and hands. The present invention also provides for various topical application formulations.

Cannabinoid formulation containing active ingredients and carrier for transdermal absorption to treat neuropathy
11311499 · 2022-04-26 · ·

The invention relates to a topical formulation in order to deliver an effective amount of broad-spectrum cannabidiol ointment, in conjunction with active ingredients, menthol and camphor. This invention is for the treatment of symptoms and improvement of sensation associated with peripheral neuropathy, particularly of the feet and hands. The present invention also provides for various topical application formulations.

METHOD FOR IMPROVING PREPARATION OF FERMENTED BLACK GINSENG CONTAINING HIGH CONTENT OF FUNCTIONAL INGREDIENTS BASED ON SAFETY BY APPLYING LED
20230241147 · 2023-08-03 ·

The present invention relates to a method for improving the preparation of fermented black color ginseng containing functional ingredients at high contents based on safety, specifically to a novel Aspergillus niger KHNT-1 strain deposited with accession number KCTC14739BP; an improved process for preparing fermented black color ginseng through treatment with the strain, steaming utilizing pottery, and drying utilizing an LED dryer; fermented black color ginseng containing functional ingredients, ginsenosides Rg5, Rg3, and Rk1, and CK at high contents; and a composition for preventing, improving, or treating coronavirus infectious disease, the composition containing the fermented black color ginseng as an active ingredient.

As the fermented black color ginseng is prepared through fermentation using the novel Aspergillus niger KHNT-1 strain according to the present invention, steaming utilizing pottery as a steamer, and drying (fermentation) utilizing a medical LED as a dryer/fermenter, the method for improving the preparation of fermented black color ginseng is economical and safe since the preparation process takes 7 to 15 days and benzopyrene is not detected in the fermented black color ginseng, and the fermented black color ginseng contains ginsenosides Rg3, Rg5, and Rk1, and CK at high contents, and can be usefully utilized as a high value-added new drug raw material that is required to be contained at a high content per unit and in the field of high-functional food development.

ISOLATION AND CHARACTERIZATION OF ANTICANCER COMPOUND FROM SESUVIUM PORTULACASTRUM (L.) L.
20220024872 · 2022-01-27 ·

The invention discloses a novel anticancer compound, 3, 4, 5-trimethyl-2-(4-(8-methylnonyl)phenyl)pyridine extracted from Sesuvium portulacastrum (S. portulacastrum) having the structure as represented by Formula (I). The invention also discloses a method of extraction of this anticancer compound, 3, 4, 5-trimethyl-2-(4-(8-methylnonyl)phenyl)pyridine from S. portulacastrum. The invention further relates to characterization of the anticancer compound, 3, 4, 5-trimethyl-2-(4-(8-methylnonyl)phenyl)pyridine and study of its effect on the cancer cell cycle progression and expression of genes involved in apoptosis.

##STR00001##

CANNABINOID FORMULATION CONTAINING ACTIVE INGREDIENTS AND CARRIER FOR TRANSDERMAL ABSORPTION TO TREAT NEUROPATHY
20220016047 · 2022-01-20 ·

The invention relates to a topical formulation in order to deliver an effective amount of broad-spectrum cannabidiol ointment, in conjunction with active ingredients, menthol and camphor. This invention is for the treatment of symptoms and improvement of sensation associated with peripheral neuropathy, particularly of the feet and hands. The present invention also provides for various topical application formulations.

ANTIBACTERIAL AND ANTIVIRUS COMPOSITION COMPRISING Extract of CANNABIS SATIVA L.
20220016193 · 2022-01-20 ·

The present disclosure relates to an antibacterial and antiviral composition containing an extract of Cannabis sativa L. as an active ingredient. More specifically, the present disclosure provides an antibacterial and antiviral composition which contains an extract of the natural product Cannabis sativa L., and thus may exhibit antibacterial and antiviral activities, and when taken or administered, has no side effects and does not cause bacterial or viral resistance.

METHODS AND SYSTEMS FOR THE SELECTIVE EXTRACTION OF PHYTOCHEMICALS
20230293612 · 2023-09-21 ·

The present application relates to the extraction of phytochemicals, more specifically to methods and systems for the selective extraction of phytochemicals from biomass. A method may comprises placing the biomass into a thermal chamber, the thermal chamber being connected with an eductor through a suction connection, and a discharge port of the eductor being connected to a concentrate tank; generating a vacuum in the thermal chamber by circulating a motive fluid through the eductor; heating the biomass to volatilize one or more phytochemicals; condensing the one or more volatilized phytochemicals by contacting the volatized phytochemicals with the motive fluid; and collecting the one or more condensed phytochemicals into the concentrate tank.

COMMIPHORA MOLMOL (MYRRH) RESIN EXTRACTS AND USES THEREOF FOR WOUND HEALING AND TREATMENT AND PREVENTION OF MUCOSITIS AND OTHER DISEASES
20210353700 · 2021-11-18 ·

Provided herein are compositions comprising acidic extracts of Commiphora molmol (Myrrh) resin for the treatment and prevention of oral mucositis, mucosal infections, topical inflammations, bed sores, decubitis, inflammations of the gastrointestinal tract, canker sores, dental mouth lining ulcers, Behcet disease, and for acute and chronic wound healing. Also provided are methods for producing the disclosed compositions.

Ear-cleansing agent for companion animals and method of manufacturing the same
11219591 · 2022-01-11 · ·

The present invention relates to an ear-cleansing agent for companion animals and a method of manufacturing the same. More particularly, the present invention relates to an ear-cleansing agent for companion animals, which includes distilled Chamaecyparis obtusa water extracted from Chamaecyparis obtusa trees so as to enable antibacterial action, deodorization, and exfoliation and which does not include a surfactant so that the skin is not irritated even when the ear-cleansing agent is not washed away using water, and a method of manufacturing the same.